1 active not recruiting, 1 completed, 1 terminated. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
Follow B-Cell: new trials by email Literature Review of B-Cell trials Research Report on B-Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia rhIL-15, Obinutuzumab - Leukemia, Lymphocytic | Phase 1 | Terminated | National Cancer Institute (NCI) | 1 | 2019-07-11 | 2022-03-22 |
| Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Lenalidomide, Obinutuzumab, Venetoclax - B-Cell Lymphoma, Unspecified, Grade 1 Follicular Lymphoma | Phase 1 | Active not recruiting | Beth Christian | 22 | 2017-02-21 | 2026-09-24 |
| A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment Chi Lob 7/4 (A chimeric monoclonal antibody) - Cancer, Neoplasms | Phase 1 | Completed | Cancer Research UK | 29 | 2007-07-01 | 2014-12-02 |
Bronchiolitis Obliterans Syndrome (1) · Burkitt Lymphoma (1) · Leukemia (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Neoplasms (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Neoplasms by Histologic Type (3) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Graft vs Host Disease (1) · Hematologic Diseases (1)
obinutuzumab (2) · Interleukin-15 (1) · Lenalidomide (1) · venetoclax (1)
Beth Christian (1) · Cancer Research UK (1) · National Cancer Institute (NCI) (1)
United States (2) · United Kingdom (1)
Beth Christian, MD (1) · Kevin C Conlon, M.D. (1) · Peter W Johnson, Professor (1)